Bvf Inc Syndax Pharmaceuticals Inc Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$11.39 - $21.67 $21.4 Million - $40.6 Million
1,875,000 New
1,875,000 $40.5 Million
Q1 2023

May 15, 2023
BUY
$20.66 - $28.98 $14.3 Million - $20.1 Million
692,000 Added 47.68%
2,143,197 $45.3 Million
Q4 2022

Feb 14, 2023
SELL
$20.64 - $26.24 $7.16 Million - $9.1 Million
-346,888 Reduced 19.29%
1,451,197 $36.9 Million
Q3 2022

Nov 14, 2022
SELL
$18.51 - $24.79 $10.3 Million - $13.9 Million
-558,849 Reduced 23.71%
1,798,085 $43.2 Million
Q2 2022

Aug 15, 2022
SELL
$13.64 - $19.48 $515,319 - $735,954
-37,780 Reduced 1.58%
2,356,934 $45.3 Million
Q1 2022

May 16, 2022
BUY
$14.84 - $22.15 $4.38 Million - $6.53 Million
295,000 Added 14.05%
2,394,714 $41.6 Million
Q4 2021

Feb 14, 2022
SELL
$15.23 - $22.47 $5.89 Million - $8.69 Million
-386,715 Reduced 15.55%
2,099,714 $46 Million
Q2 2021

Aug 16, 2021
BUY
$13.42 - $25.18 $31.2 Million - $58.5 Million
2,322,905 Added 1420.53%
2,486,429 $42.7 Million
Q1 2021

May 17, 2021
SELL
$19.28 - $24.59 $13.8 Million - $17.6 Million
-715,000 Reduced 81.39%
163,524 $3.66 Million
Q4 2020

Feb 12, 2021
SELL
$15.1 - $26.44 $24 Million - $42.1 Million
-1,592,154 Reduced 64.44%
878,524 $19.5 Million
Q2 2020

Aug 14, 2020
BUY
$8.94 - $20.98 $2.96 Million - $6.94 Million
330,894 Added 15.46%
2,470,678 $36.6 Million
Q1 2020

May 15, 2020
BUY
$6.65 - $12.03 $2.49 Million - $4.51 Million
375,000 Added 21.25%
2,139,784 $23.5 Million
Q2 2019

Aug 14, 2019
SELL
$4.9 - $9.31 $1.09 Million - $2.08 Million
-222,885 Reduced 11.21%
1,764,784 $16.4 Million
Q4 2018

Feb 14, 2019
BUY
$3.6 - $8.42 $2.71 Million - $6.35 Million
754,051 Added 61.13%
1,987,669 $8.85 Million
Q2 2018

Aug 14, 2018
SELL
$6.93 - $14.63 $13.9 Million - $29.3 Million
-2,000,000 Reduced 61.85%
1,233,618 $8.66 Million
Q4 2017

Feb 14, 2018
BUY
$7.8 - $12.94 $25.2 Million - $41.8 Million
3,233,618
3,233,618 $28.3 Million

Others Institutions Holding SNDX

# of Institutions
230
Shares Held
90M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email